1-4 of 4
Roch Houot, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First Results of the Acsé Pembrolizumab Phase II in the Primary CNS Lymphoma (PCNSL) Cohort

Khe Hoang-Xuan, MDPhD, Roch Houot, MDPhD, Carole Soussain, MD PhD, Marie Blonski, MD, Anna Schmitt, MD, Vincent Delwail, MD, Gandhi Laurent Damaj, MD PhD, Herve Ghesquieres, MD PhD, Frédéric Peyrade, MD, Adrian Tempescul, MD, Julie Abraham, MD, Philippe Agape, MD, Guido Ahle, MD, Nathalie Baize, MD, Pierre Bories, MD, Chantal Campello, MD, Emmanuel Gyan, MD PhD, Fabrice Jardin, MD PhD, Philippe Rey, MD, Sylvain Choquet, MD, Caroline Houillier, MD, Nathalie Cassoux, MDPhD, Valerie Touitou, MDPhD, Nadine Martin-Duverneuil, MD, Frederic Legrand, Assia Lamrani-Ghaouti, Ophelie Querel, Natalie Hoog Labouret, MD, Clotilde Simon, Sylvie Chevret, MDPhD, Christophe Massard, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-141773
Published: 2020
Journal Articles

Pre-Planned Interim Safety Analysis of the Niveau Trial, a Randomized Phase 3 Study for Patients with Aggressive Non-Hodgkin Lymphoma in First Relapse or Progression Not Eligible for High-Dose Chemotherapy (HDT), Testing Nivolumab in Combination with Gemcitabine, Oxaliplatin (GemOx) Plus Rituximab (R) in Case of B-Cell Lymphoma

Lorenz Thurner, MD, Viola Poeschel, MD, Bettina Altmann, PhD, Herve Tilly, MD PhD, Marc Andre, MD, Marie Maerevoet, MD, Thomas Weber, MD, Joerg Hoffmann, MD, Martin Dreyling, MD, Herve Maisonneuve, MD, Andrea Kerkhoff, MD, Steven Le Gouill, MD PhD, Stephan Stilgenbauer, MD, Marita Ziepert, PhD, Roch Houot, MDPhD, Corinne Haioun, MDPhD, Gerhard Held, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32.
https://doi.org/10.1182/blood-2020-139459
Published: 2020
Journal Articles

Nivolumab in Combination with Gemcitabine and Oxaliplatin (GemOx) in Relapse/Refractory T-Cell Lymphoma: Preliminary Results of the Experimental Arm of the Niveau Trial

Roch Houot, MDPhD, Viola Poeschel, MD, Bettina Altmann, PhD, Thomas Illmer, MD, Marc André, MD, Martin Dreyling, MD, Herve Maisonneuve, MD, Herve Tilly, MD PhD, Stephanie Mayer, MD, Rene-Olivier Casasnovas, MD, Steven Le Gouill, MD PhD, Fritz C. Offner, MD PhD, Guillaume Cartron, MD PhD, Andrea Kerkhoff, MD, Thomas Weber, MD, Joerg Hoffmann, MD, Marita Ziepert, PhD, Wolfram Klapper, MD, Emmanuel Itti, MD PhD, Dirk Hellwig, Laurence De Leval, MD, Andreas Rosenwald, MD, Corinne Haioun, MD PhD, Laurent Dercle, MD, Philippe Gaulard, MD PhD, Gerhard Held, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-136941
Published: 2020
Journal Articles

R-CHOP14 As a Standard of Care in Primary Mediastinal B Cell Lymphoma: A 10-YEARS Experience of Lysa Centers

Vincent Camus, Alina Berriolo-Riedinger, Justine Lequesne, David Tonnelet, MD, Pierre Decazes, Cédric Rossi, MD PhD, Pierre Sesques, MD, Corinne Haioun, MD PhD, Eric Durot, MD, Alexandre Willaume, Martin Gauthier, Marie-Pierre Moles, MD, Chloe Antier, Julien Lazarovici, MD, Helene Monjanel, Sophie Bernard, Magalie Tardy, Caroline Besson, MDPhD, Laure Lebras, MD, Choquet Sylvain, Katell Le Du, MD, Christophe Bonnet, MD, Sarah Bailly, MD, Damaj Gandhi Laurent, MD PhD, Kamel Laribi, MD, Herve Maisonneuve, MD, Roch Houot, MDPhD, Adrien Chauchet, MD, Fabrice Jardin, MD PhD, Stephanie Becker, MD, Herve Tilly, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-136600
Published: 2020